These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20832801)

  • 1. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
    Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1.
    Huertas-Vazquez A; Aguilar-Salinas C; Lusis AJ; Cantor RM; Canizales-Quinteros S; Lee JC; Mariana-Nuñez L; Riba-Ramirez RM; Jokiaho A; Tusie-Luna T; Pajukanta P
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1985-91. PubMed ID: 15976322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): a reappraisal by using a resequencing approach.
    Minicocci I; Prisco C; Montali A; Di Costanzo A; Ceci F; Pigna G; Arca M
    Atherosclerosis; 2015 Oct; 242(2):618-24. PubMed ID: 26342331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor alpha (TNFalpha) and its soluble receptor p75 (sTNF-R p75) in familial combined hyperlipidemia (FCHL).
    Cavallo MG; Montali A; Monetini L; Valente L; Mariani P; Bifolco M; Sirinian MI; Antonini TM; Fioretti F; Campagna F; Verna R; Arca M
    Nutr Metab Cardiovasc Dis; 2005 Aug; 15(4):262-9. PubMed ID: 16054550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment.
    Arca M; Cambuli VM; Montali A; Sentinelli F; Filippi E; Campagna F; Quagliarini F; Antonini R; Romeo S; Baroni MG
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):660-6. PubMed ID: 19632099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia.
    Hoffer MJ; Snieder H; Bredie SJ; Demacker PN; Kastelein JJ; Frants RR; Stalenhoef AF
    Atherosclerosis; 2000 Aug; 151(2):443-50. PubMed ID: 10924721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.
    Meijssen S; Derksen RJ; Bilecen S; Erkelens DW; Cabezas MC
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1576-80. PubMed ID: 11932285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia.
    Geurts JM; Janssen RG; van Greevenbroek MM; van der Kallen CJ; Cantor RM; Bu X; Aouizerat BE; Allayee H; Rotter JI; de Bruin TW
    Hum Mol Genet; 2000 Sep; 9(14):2067-74. PubMed ID: 10958645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.
    Eichenbaum-Voline S; Olivier M; Jones EL; Naoumova RP; Jones B; Gau B; Patel HN; Seed M; Betteridge DJ; Galton DJ; Rubin EM; Scott J; Shoulders CC; Pennacchio LA
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):167-74. PubMed ID: 14551155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose Triglyceride Lipase Gene Polymorphisms is Not Associated with Free Fatty Acid Levels in Chinese Han Population.
    Liu N; Yang G; Hu M; Han J; Cai Y; Hu Z; Jia C; Zhang M
    Metab Syndr Relat Disord; 2017 Nov; 15(9):474-479. PubMed ID: 29072982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism.
    Garcia-Rios A; Delgado-Lista J; Perez-Martinez P; Phillips CM; Ferguson JF; Gjelstad IM; Williams CM; Karlström B; Kieć-Wilk B; Blaak EE; Lairon D; Planells R; Malczewska-Malec M; Defoort C; Riserus U; Saris WH; Lovegrove JA; Drevon CA; Roche HM; Lopez-Miranda J
    Atherosclerosis; 2011 Oct; 218(2):416-22. PubMed ID: 21840003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variants in the lipoprotein lipase gene, but not those in the insulin receptor substrate-1, the beta3-adrenergic receptor, and the intestinal fatty acid binding protein-2 genes, influence the lipid phenotypic expression in familial combined hyperlipidemia.
    Campagna F; Montali A; Baroni MG; Maria AT; Ricci G; Antonini R; Verna R; Arca M
    Metabolism; 2002 Oct; 51(10):1298-305. PubMed ID: 12370850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy.
    Arca M; Natoli S; Micheletta F; Riggi S; Di Angelantonio E; Montali A; Antonini TM; Antonini R; Diczfalusy U; Iuliano L
    Free Radic Biol Med; 2007 Mar; 42(5):698-705. PubMed ID: 17291993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families.
    Pajukanta P; Porkka KV; Antikainen M; Taskinen MR; Perola M; Murtomäki-Repo S; Ehnholm S; Nuotio I; Suurinkeroinen L; Lahdenkari AT; Syvänen AC; Viikari JS; Ehnholm C; Peltonen L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):841-50. PubMed ID: 9157946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q.
    Aouizerat BE; Allayee H; Cantor RM; Dallinga-Thie GM; Lanning CD; de Bruin TW; Lusis AJ; Rotter JI
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2730-6. PubMed ID: 10559018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.